The largest database of trusted experimental protocols

8 protocols using pen strep

1

Cell Culture Protocols for Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF10A cells have previously been described and were authenticated by short tandem repeat profiling. MDA-MB-231, HEK293T and MCF7 cells were purchased from ATCC. MCF10A cells were cultured in DMEM/F12 media (Corning, New York, NY, USA) supplemented with 5% horse serum (Invitrogen, Carlsbad, CA, USA), 1% Pen/Strep, 20 ng/mL EGF (ProSpec, East Brunswick, NJ, USA), 0.5 µg/mg hydrocortisone, 100 ng/mL cholera toxin and 10 µg/mL insulin. MDA-MB-231, HEK293T and MCF7 cells were cultured in DMEM supplemented with 10% fetal bovine serum and 1% Pen/Strep. All cells were cultured in a humidified atmosphere of 95% air and 5% CO2 at 37 °C.
+ Open protocol
+ Expand
2

Isolation and Differentiation of Murine Bone Marrow-Derived Macrophages and Osteoclasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were flushed out of the long bones of the mice and the cell suspension cultured in αMEM supplemented with 10% FCS, Pen/Strep and 100 ng/ml M-CSF (Prospec Bio) for three days. Next the non-adherent cells were removed by washing the cultures with PBS, and the adherent BMDMs harvested using Acutase (Sigma) or cell dissociation buffer (Enzyme-Free; PBS-based) (Gibco, Life Technologies). For osteoclast formation experiments, cells were plated in 96-well plates at 15 × 103 cells in 100 µl medium supplemented with 25 ng/ml M-CSF and up to 100 ng/ml RANKL (a kind gift of Dr. J. Dunford, University of Oxford) per well. The culture medium was refreshed at day 2 and day 4 and the cells fixed on day 5 with 4% buffered formalin and stained for TRAP. TRAP positive cells containing three or more nuclei were counted as osteoclasts. For RNA isolation, BMDM cells were seeded in 6-well plates at 5 × 105 cells per well in medium supplemented with 25 ng/ml M-CSF only (for macrophage cultures) or 25 ng/ml M-CSF plus 100 ng/ml RANKL (for osteoclast cultures) and cultured for 5 days as described above. For Western Blot analysis, BMDM cells were seeded in 6-well plates at 5 × 105 cells per well in medium supplemented with 25 ng/ml M-CSF and cultured for 3 days.
+ Open protocol
+ Expand
3

Competitive Repopulating Unit Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Competitive repopulating unit (CRU) assays were performed as previously described29 (link) using limiting numbers of BMNCs from CD45.1 donor mice. Freshly isolated BMNCs were immediately used for BM transplantation, or BMNCs were co-cultured with rMSCs for 6 days in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of TPO (PROSPEC) and 20ng/ml of stem cell factor (SCF; PEPROTEC), then collected and CD45+ cells were isolated by MACS column (Miltenyi Biotec), and finally a fraction of the cultured cells corresponding to the indicated number (1,000, 2,500, 5,000, 12,500 and 25,000) of initial BMNCs was subjected to BM transplantation. The test cells (CD45.1) were transplanted together with 2 x 105 competitor BMNCs (CD45.2) into CD45.2 recipient mice lethally irradiated (12 Gy, two split doses). The percentage of donor (CD45.1+) cells in the PB was determined 16 weeks later by flow cytometry. Mice with more than 1 % in all three lineages (myeloid, B and T cells) were considered positive and the others were defined as negative mice. The CRU frequency was calculated using L-Calc software (STEMCELL Technologies).
+ Open protocol
+ Expand
4

Ex Vivo Expansion of Human HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ human cord blood (Lonza) was obtained according to an institutional review board-approved protocol. 13,600 CD34+ cells were co-cultured with murine rMSCs in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of human TPO (PROSPEC). After co-culture for 6 days, the number of phenotypic LinCD34+CD38CD90+CD49f+ human HSCs was assessed by FACS analysis.
+ Open protocol
+ Expand
5

Competitive Repopulating Unit Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Competitive repopulating unit (CRU) assays were performed as previously described29 (link) using limiting numbers of BMNCs from CD45.1 donor mice. Freshly isolated BMNCs were immediately used for BM transplantation, or BMNCs were co-cultured with rMSCs for 6 days in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of TPO (PROSPEC) and 20ng/ml of stem cell factor (SCF; PEPROTEC), then collected and CD45+ cells were isolated by MACS column (Miltenyi Biotec), and finally a fraction of the cultured cells corresponding to the indicated number (1,000, 2,500, 5,000, 12,500 and 25,000) of initial BMNCs was subjected to BM transplantation. The test cells (CD45.1) were transplanted together with 2 x 105 competitor BMNCs (CD45.2) into CD45.2 recipient mice lethally irradiated (12 Gy, two split doses). The percentage of donor (CD45.1+) cells in the PB was determined 16 weeks later by flow cytometry. Mice with more than 1 % in all three lineages (myeloid, B and T cells) were considered positive and the others were defined as negative mice. The CRU frequency was calculated using L-Calc software (STEMCELL Technologies).
+ Open protocol
+ Expand
6

Ex Vivo Expansion of Human HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD34+ human cord blood (Lonza) was obtained according to an institutional review board-approved protocol. 13,600 CD34+ cells were co-cultured with murine rMSCs in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of human TPO (PROSPEC). After co-culture for 6 days, the number of phenotypic LinCD34+CD38CD90+CD49f+ human HSCs was assessed by FACS analysis.
+ Open protocol
+ Expand
7

Cord Blood CD34+ Cell Transplantation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRU assays were performed using limiting numbers of CD34+ cells from human cord blood (Lonza). Freshly isolated non-cultured human cord blood CD34+ cells were immediately used for BM transplantation, or human cord blood CD34+ cells were co-cultured with murine rMSCs for 6 days in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of human TPO (PROSPEC) and 20ng/ml of human SCF (PROSPEC), then collected and human CD45+ cells were isolated by MACS column (Miltenyi Biotec), and finally a fraction of the cultured cells corresponding to the indicated number (0.2, 1, 3 and 5 × 103) of initial cord blood cells was subjected to BM transplantation. The test cells (human CD45+) were transplanted into NOD-scid Il2rg/ (NSG) immunocompromised mice sublethally irradiated (2 Gy) together with 2 x 105 competitor BMNCs (NSG). The percentage of donor (human CD45+) cells in the PB was determined 16 weeks later by flow cytometry. Mice with more than 1% were considered positive and the others were defined as negative mice. The CRU frequency was calculated using L-Calc software (STEMCELL Technologies).
+ Open protocol
+ Expand
8

Cord Blood CD34+ Cell Transplantation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRU assays were performed using limiting numbers of CD34+ cells from human cord blood (Lonza). Freshly isolated non-cultured human cord blood CD34+ cells were immediately used for BM transplantation, or human cord blood CD34+ cells were co-cultured with murine rMSCs for 6 days in StemSpan SFEM media (STEMCELL Technologies) supplemented with 10 % KnockOut Serum Replacement (Thermo Fisher Scientific), Pen/Strep, 10ng/ml of human TPO (PROSPEC) and 20ng/ml of human SCF (PROSPEC), then collected and human CD45+ cells were isolated by MACS column (Miltenyi Biotec), and finally a fraction of the cultured cells corresponding to the indicated number (0.2, 1, 3 and 5 × 103) of initial cord blood cells was subjected to BM transplantation. The test cells (human CD45+) were transplanted into NOD-scid Il2rg/ (NSG) immunocompromised mice sublethally irradiated (2 Gy) together with 2 x 105 competitor BMNCs (NSG). The percentage of donor (human CD45+) cells in the PB was determined 16 weeks later by flow cytometry. Mice with more than 1% were considered positive and the others were defined as negative mice. The CRU frequency was calculated using L-Calc software (STEMCELL Technologies).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!